Cited 0 times in 
Cited 0 times in 
Comparative effects of sevoflurane and desflurane on postoperative renal function in patients with type 2 Diabetes mellitus
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Park, Jae Hyon | - |
| dc.contributor.author | Park, Insun | - |
| dc.contributor.author | Nah, Sangun | - |
| dc.contributor.author | Koo, Chang-Hoon | - |
| dc.contributor.author | Joo, Yohan | - |
| dc.contributor.author | Koo, Bon-Wook | - |
| dc.contributor.author | Yoon, Jongjin | - |
| dc.date.accessioned | 2026-01-19T07:59:06Z | - |
| dc.date.available | 2026-01-19T07:59:06Z | - |
| dc.date.created | 2026-01-14 | - |
| dc.date.issued | 2025-12 | - |
| dc.identifier.issn | 0886-022X | - |
| dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/209947 | - |
| dc.description.abstract | Background: Although sevoflurane is widely used for general anesthesia, its potential nephrotoxicity remains a concern, particularly in patients with type 2 diabetes mellitus (T2DM). This study compared the renal effects of sevoflurane and desflurane in T2DM patients, focusing on renal cortical fat fraction (RCFF) from preoperative magnetic resonance imaging (MRI). Methods: In this retrospective cohort study, adult T2DM patients who underwent non-cardiac surgery >3 h under sevoflurane or desflurane anesthesia were included if they had preoperative abdominal MRI with proton density fat fraction sequences. The primary outcome was a sustained decline in estimated glomerular filtration rate (eGFR), defined as a >= 25% decrease from baseline persisting through postoperative day 7. Propensity score matching (PSM) was performed to minimize confounding, and multivariate logistic regression was used to identify predictors of eGFR decline. Results: A total of 158 patients were analyzed after PSM. Overall, 91/158 (57.6%) experienced a sustained decline in eGFR. The incidence did not differ significantly between groups: 50/79 (63.3%) in the sevoflurane group vs. 41/79 (51.9%) in the desflurane group (p = 0.198). In subgroup analysis, lower preoperative eGFR and RCFF were independent predictors of eGFR decline only in the sevoflurane group. An RCFF threshold of 2% identified increased risk; patients with RCFF <2% had a higher rate of eGFR decline under sevoflurane (81.8% vs. 53.3%, p = 0.040), but not under desflurane. Conclusion: T2DM patients with low RCFF (<2%) may be more susceptible to postoperative renal dysfunction following sevoflurane anesthesia. Further studies are needed to confirm this association. | - |
| dc.language | English | - |
| dc.publisher | Informa Healthcare | - |
| dc.relation.isPartOf | RENAL FAILURE | - |
| dc.relation.isPartOf | RENAL FAILURE | - |
| dc.subject.MESH | Aged | - |
| dc.subject.MESH | Anesthetics, Inhalation* / adverse effects | - |
| dc.subject.MESH | Desflurane* / adverse effects | - |
| dc.subject.MESH | Diabetes Mellitus, Type 2* / complications | - |
| dc.subject.MESH | Female | - |
| dc.subject.MESH | Glomerular Filtration Rate / drug effects | - |
| dc.subject.MESH | Humans | - |
| dc.subject.MESH | Kidney* / diagnostic imaging | - |
| dc.subject.MESH | Kidney* / drug effects | - |
| dc.subject.MESH | Kidney* / physiopathology | - |
| dc.subject.MESH | Magnetic Resonance Imaging | - |
| dc.subject.MESH | Male | - |
| dc.subject.MESH | Middle Aged | - |
| dc.subject.MESH | Postoperative Complications* / chemically induced | - |
| dc.subject.MESH | Postoperative Complications* / epidemiology | - |
| dc.subject.MESH | Postoperative Period | - |
| dc.subject.MESH | Propensity Score | - |
| dc.subject.MESH | Retrospective Studies | - |
| dc.subject.MESH | Sevoflurane* / adverse effects | - |
| dc.title | Comparative effects of sevoflurane and desflurane on postoperative renal function in patients with type 2 Diabetes mellitus | - |
| dc.type | Article | - |
| dc.contributor.googleauthor | Park, Jae Hyon | - |
| dc.contributor.googleauthor | Park, Insun | - |
| dc.contributor.googleauthor | Nah, Sangun | - |
| dc.contributor.googleauthor | Koo, Chang-Hoon | - |
| dc.contributor.googleauthor | Joo, Yohan | - |
| dc.contributor.googleauthor | Koo, Bon-Wook | - |
| dc.contributor.googleauthor | Yoon, Jongjin | - |
| dc.identifier.doi | 10.1080/0886022X.2025.2583611 | - |
| dc.relation.journalcode | J02604 | - |
| dc.identifier.eissn | 1525-6049 | - |
| dc.identifier.pmid | 41292116 | - |
| dc.subject.keyword | Desflurane | - |
| dc.subject.keyword | diabetes mellitus | - |
| dc.subject.keyword | glomerular filtration rate | - |
| dc.subject.keyword | kidney diseases | - |
| dc.subject.keyword | magnetic resonance imaging | - |
| dc.subject.keyword | sevoflurane | - |
| dc.contributor.affiliatedAuthor | Joo, Yohan | - |
| dc.contributor.affiliatedAuthor | Yoon, Jongjin | - |
| dc.identifier.scopusid | 2-s2.0-105022996929 | - |
| dc.identifier.wosid | 001626963900001 | - |
| dc.citation.volume | 47 | - |
| dc.citation.number | 1 | - |
| dc.identifier.bibliographicCitation | RENAL FAILURE, Vol.47(1), 2025-12 | - |
| dc.identifier.rimsid | 90847 | - |
| dc.type.rims | ART | - |
| dc.description.journalClass | 1 | - |
| dc.description.journalClass | 1 | - |
| dc.subject.keywordAuthor | Desflurane | - |
| dc.subject.keywordAuthor | diabetes mellitus | - |
| dc.subject.keywordAuthor | glomerular filtration rate | - |
| dc.subject.keywordAuthor | kidney diseases | - |
| dc.subject.keywordAuthor | magnetic resonance imaging | - |
| dc.subject.keywordAuthor | sevoflurane | - |
| dc.subject.keywordPlus | LOW-FLOW DESFLURANE | - |
| dc.subject.keywordPlus | GFR DECLINE | - |
| dc.subject.keywordPlus | ANESTHESIA | - |
| dc.subject.keywordPlus | INJURY | - |
| dc.subject.keywordPlus | OBESITY | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalWebOfScienceCategory | Urology & Nephrology | - |
| dc.relation.journalResearchArea | Urology & Nephrology | - |
| dc.identifier.articleno | 2583611 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.